AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Experimental Cold Drug May Aid SARS Fight.
By David Wahlberg, The Atlanta Journal-Constitution Knight Ridder/Tribune Business News
May 14--An experimental drug for the common cold could be a starting point for finding a treatment for SARS, German researchers said Tuesday.
The drug, made by Pfizer and known only as AG-7088, is in clinical trials.
It attacks the rhinovirus, a cause of colds, by blocking an enzyme the virus needs to replicate itself. The enzyme, called "protease," is targeted --- in a slightly different way --- in AIDS drugs known as protease inhibitors.
AG-7088 could be modified to attack the coronavirus that causes SARS, scientists from the University of Lubeck …
-
- The Atlanta Journal and Constitution E-Business News Column.
-
Newspaper article from: The Atlanta Journal-Constitution
September 20, 2000
700+ words
-
- The Atlanta Journal-Constitution business queries column.
-
News wire article from: Knight Ridder/Tribune Business News
February 5, 2005
700+ words
-
- The Atlanta Journal-Constitution Residential Real Estate Column.
-
News wire article from: Knight Ridder/Tribune Business News
May 23, 2003
700+ words
-
- The Atlanta Journal-Constitution Test Drive Column.
-
News wire article from: Knight Ridder/Tribune Business News
May 9, 2003
700+ words
-
- The Atlanta Journal-Constitution Business Press Column.
-
News wire article from: Knight Ridder/Tribune Business News
May 21, 2003
700+ words
